Drug & Medication Database

Browse 18,617 FDA-approved medications with detailed information about uses, dosage, side effects, and interactions.

Mirtazapine

mirtazapine

OTC

11 DESCRIPTION Mirtazapine tablets, USP contain mirtazapine. Mirtazapine has a tetracyclic chemical structure and belongs to the piperazino-azepine group of compounds. It is designated 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c]benzazepine and has the molecular formula of C 17 H 19 N 3 . Its molecular weight is 265.36.

Brands: Mirtazapine

Mirtazapine (process-ii)

mirtazapine (process-ii)

OTC

Dosage form: POWDER. Active ingredients: MIRTAZAPINE (50 kg/50kg). Category: BULK INGREDIENT.

Mirtazapine Anhydrous

mirtazapine anhydrous

OTC

Dosage form: POWDER. Active ingredients: MIRTAZAPINE (50 kg/50kg). Category: BULK INGREDIENT.

Mirvetuximab Soravtansine

mirvetuximab soravtansine

OTC

11 DESCRIPTION Mirvetuximab soravtansine-gynx is a folate receptor alpha (FRα)-directed antibody-drug conjugate (ADC) consisting of three components: 1) an anti-FRα monoclonal antibody of IgG1 subtype 2) the small molecule anti-tubulin agent DM4 (a maytansine derivative) and 3) a linker, sulfo-SPDB (1-(2,5-dioxopyrrolidin-1-yl)oxy-1-oxo-4-(pyridin-2-yldisulfanyl)butane-2-sulfonic acid) that covalently attaches DM4 to the mirvetuximab antibody.

Brands: Elahere

Mirvetuximab Soravtansine Gynx

mirvetuximab soravtansine gynx

OTC

Dosage form: INJECTION. Active ingredients: MIRVETUXIMAB SORAVTANSINE-GYNX (100 mg/20mL). Category: DRUG FOR FURTHER PROCESSING.

Misoprostol

misoprostol

Prostaglandin E1 Analog [EPC]OTC

DESCRIPTION Misoprostol oral tablets contain either 100 mcg or 200 mcg of misoprostol, a synthetic prostaglandin E 1 analog. Misoprostol contains approximately equal amounts of the two diastereomers presented below with their enantiomers indicated by (±): Misoprostol is a water-soluble, viscous liquid. Inactive ingredients of tablets are hydrogenated vegetable oil, hypromellose, microcrystalline cellulose and sodium starch glycolate. structure

Brands: Misoprostol

Misoprostol 1% Hpmc Dispersion

misoprostol 1% hpmc dispersion

OTC

Dosage form: POWDER. Active ingredients: MISOPROSTOL (1 g/g). Category: BULK INGREDIENT.

Misoprostol Dispersion

misoprostol dispersion

OTC

Dosage form: POWDER. Active ingredients: MISOPROSTOL (1 kg/kg). Category: BULK INGREDIENT.

Misoprostol Hpmc Dispersion

misoprostol hpmc dispersion

OTC

Dosage form: POWDER. Active ingredients: MISOPROSTOL (1 g/g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.

Misoprostol-hpmc

misoprostol-hpmc

OTC

Dosage form: POWDER. Active ingredients: MISOPROSTOL (10 g/kg). Category: DRUG FOR FURTHER PROCESSING.

Mistletoe Herbal Extract Abietis 50 Mg/ml

mistletoe herbal extract abietis 50 mg/ml

OTC

Dosage form: EXTRACT. Active ingredients: VISCUM ALBUM WHOLE (50 mg/50mg). Category: BULK INGREDIENT.

Mistletoe Herbal Extract Mali 50 Mg/ml

mistletoe herbal extract mali 50 mg/ml

OTC

Dosage form: EXTRACT. Active ingredients: VISCUM ALBUM WHOLE (50 mg/50mg). Category: BULK INGREDIENT.

Mistletoe Herbal Extract Pini 50mg/ml

mistletoe herbal extract pini 50mg/ml

OTC

Dosage form: EXTRACT. Active ingredients: VISCUM ALBUM WHOLE (50 mg/50mg). Category: BULK INGREDIENT.

Mitapivat

mitapivat

Pyruvate Kinase Activator [EPC]OTC

11 DESCRIPTION The active ingredient of PYRUKYND is mitapivat, a pyruvate kinase activator, present as mitapivat sulfate. The chemical name of mitapivat sulfate is 8-quinolinesulfonamide, N-[4-[[4- (cyclopropylmethyl)-1-piperazinyl]carbonyl]phenyl]-, sulfate, hydrate (2:1:3). The chemical structure of mitapivat sulfate is: The molecular formula is (C 24 H 26 N 4 SO 3 ) 2 • H 2 SO 4 • 3H 2 O, and the molecular weight is 1053.23 for mitapivat sulfate.

Brands: Pyrukynd

Mitapivat Sulfate

mitapivat sulfate

OTC

Dosage form: POWDER. Active ingredients: MITAPIVAT SULFATE (1 kg/kg). Category: BULK INGREDIENT.

Mitochondria-derived Peptide Mots-c

mitochondria-derived peptide mots-c

OTC

Dosage form: POWDER. Active ingredients: MITOCHONDRIA-DERIVED PEPTIDE MOTS-C (1 g/g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.

Mitomycin

mitomycin

Alkylating Drug [EPC]OTC

DESCRIPTION Mitomycin, USP (also known as Mitomycin and/or Mitomycin-C) is an antibiotic isolated from the broth of Streptomyces caespitosus which has been shown to have antitumor activity. The compound is heat stable, has a high melting point, and is freely soluble in organic solvents. Mitomycin for Injection, USP is a sterile dry mixture of mitomycin, USP and mannitol, which when reconstituted with Sterile Water for Injection provides a solution for intravenous administration.

Brands: Mitomycin

Mitomycin C

mitomycin c

OTC

Dosage form: POWDER. Active ingredients: MITOMYCIN (1 mg/mg). Category: BULK INGREDIENT.

Mitotane

mitotane

OTC

11 DESCRIPTION LYSODREN (mitotane) is an oral adrenal cytotoxic agent. The chemical name is (±)-1,1-dichloro-2-( o -chlorophenyl)-2-( p -chlorophenyl) ethane (also known as o,p'-DDD). The chemical structure is: Mitotane is a white granular solid composed of clear colorless crystals. It is tasteless and has a slight pleasant aromatic odor. It is soluble in ethanol and has a molecular weight of 320.05.

Brands: Lysodren

Mitoxantrone

mitoxantrone

OTC

DESCRIPTION Mitoxantrone Injection, USP (concentrate) is a synthetic antineoplastic anthracenedione for intravenous use. The molecular formula is C 22 H 28 N 4 O 6 ∙2HCl and the molecular weight is 517.41. It is supplied as a concentrate that MUST BE DILUTED PRIOR TO INJECTION.

Brands: Mitoxantrone

Mitoxantrone Hydrochloride

mitoxantrone hydrochloride

OTC

DESCRIPTION: Mitoxantrone Injection, USP (concentrate) is a synthetic antineoplastic anthracenedione for intravenous use. It is supplied as a concentrate that MUST BE DILUTED PRIOR TO INJECTION. The concentrate is a sterile, nonpyrogenic, dark blue aqueous solution containing mitoxantrone hydrochloride equivalent to 2 mg/mL mitoxantrone free base, with the following inactive ingredients: sodium chloride (0.800% w/v), sodium acetate (0.005% w/v), acetic acid (0.046% w/v), and water for injection.

Brands: Mitoxantrone

Mivacurium Chloride

mivacurium chloride

OTC

Dosage form: POWDER. Active ingredients: MIVACURIUM CHLORIDE (1 g/g). Category: BULK INGREDIENT.

Mivacurium Chloride 4%

mivacurium chloride 4%

OTC

Dosage form: POWDER. Active ingredients: MIVACURIUM CHLORIDE (1 kg/kg). Category: BULK INGREDIENT.

Mixed Feathers

mixed feathers

OTC

Dosage form: INJECTION, SOLUTION. Route: SUBCUTANEOUS. Active ingredients: ANAS PLATYRHYNCHOS FEATHER (.005 g/mL); ANSER ANSER FEATHER (.05 g/mL); GALLUS GALLUS FEATHER (.05 g/mL). Category: BLA.

Brands: Mixed Feathers

Mixed Ragweed

mixed ragweed

OTC

Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: AMBROSIA ARTEMISIIFOLIA POLLEN (.1 g/mL); AMBROSIA TRIFIDA POLLEN (.1 g/mL). Category: BLA.

Brands: Mixed Ragweed

Mixed Vespid Hymenoptera Venom Multidose

mixed vespid hymenoptera venom multidose

OTC

Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. Route: SUBCUTANEOUS. Active ingredients: DOLICHOVESPULA ARENARIA VENOM PROTEIN (100 ug/mL); DOLICHOVESPULA MACULATA VENOM PROTEIN (100 ug/mL); VESPULA GERMANICA VENOM PROTEIN (20 ug/mL); VESPULA MACULIFRONS VENOM PROTEIN (20 ug/mL); VESPULA PENSYLVANICA VENOM PROTEIN (20 ug/mL); VESPULA SQUAMOSA VENOM PROTEIN (20 ug/mL); VESPULA VULGARIS VENOM PROTEIN (20 ug/mL). Category: BLA.

Brands: Mixed Vespid Hymenoptera Venom Multidose, Mixed Vespid Hymenoptera Venom

Mixed Vespid Hymenoptera Venom Venomil Maintenance

mixed vespid hymenoptera venom venomil maintenance

OTC

Dosage form: KIT. Route: SUBCUTANEOUS. Category: BLA.

Brands: Mixed Vespid Hymenoptera Venom Venomil Maintenance

Mk-2866

mk-2866

OTC

Dosage form: POWDER. Active ingredients: ENOBOSARM (1 g/g). Category: BULK INGREDIENT.

Mk677

mk677

OTC

Dosage form: POWDER. Active ingredients: IBUTAMOREN (1 g/g). Category: BULK INGREDIENT.

Mnb Rlp2086 Subfamily A Protein

mnb rlp2086 subfamily a protein

OTC

Dosage form: SUSPENSION. Active ingredients: NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN (.06 mg/.06mg). Category: DRUG FOR FURTHER PROCESSING.

Medical Disclaimer

This drug database is for informational purposes only. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.